Financial Information

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Financial Information

Filing date Form Description Filing Group View
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
EFFECT

EFFECT

Other
View HTML
CERTNAS

CERTNAS

Other
View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1

Registration statement for face-amount certificate companies

Registration Statements
View HTML
D
Other
View HTML
D
Other
View HTML